low as 10% differences in DNA methylation. In addition, the assay showed fairly good reproducibility (% RSD= <5%) with better sensitivity and specificity by analysing various levels of methylation in two cell lines and eight fresh tissues samples from patients with oesophageal squamous cell carcinoma. Finally, the method was validated with methylation specific-high resolution melting curve analysis and Sanger sequencing methodsto study the methylation in oesophageal cancer samples.
Introduction
DNA methylation is one of the clinically relevant epigenetic biomarkers that regulate gene expression via controlling transcriptional alteration, genomic stability, X chromosome inactivation, genomic imprinting and mammalian cell development [1] . Recent studies on epigenetic research demonstrate that aberrant DNA methylationplays a critical role in the pathophysiology of human cancers including oesophageal squamous cell carcinoma (ESCC) [2, 3] . For example, gene-specific promoter hypermethylation is an important driver in the development and progression of many human cancers viatranscriptional inactivation and suppressing of gene function [4] [5] [6] [7] [8] .More recently, it has also been demonstrated that DNA methylation can be used as tumour-specific therapeutic targets in ESCC [2] .Therefore,sensitive and specific profiling of gene specific DNA methylation in ESCC could have potential implication for prediction of prognosis as well as to therapy response in clinical settings.
Until recently, gene specific DNA methylation in ESCC is generally detected via methylation specific PCR approaches along with bisulfite sequencing [9, 10] . Over the past several decades,a variety of molecular biological approaches includingmethylation-sensitive single nucleotide-primer extension, methylight, methylation-sensitive high resolution melting, enzyme-linked immunosorbent assay (ELISA) based methylation assays, mass spectroscopy and fluorescence readout based methodshave been conspicuously exploited to quantify the level of the DNA methylation in many human cancers [11] [12] [13] [14] [15] . However, most of these approaches are relatively simpler and robust but typically require large sample volumes, sophisticated instruments, multi-step procedures, hazardous radiolabeling, complex fabrication, expensive antibodies, etc. Furthermore, these assays are affected by multiple external controls for quantitative analysis, background fluorescence interference, high labour and bioinformatics costswhich limit their use in routine clinical applications.
In recent years, much attention has been focused on thedevelopment ofsensitive, specific, relatively simple and inexpensive method for the analysis ofDNA methylation using electrochemistry, colorimetry, surface plasmon resonance and Raman scattering readouts [17] [18] [19] [20] [21] [22] .While most of these readout methods have theirown merits and demerits, electrochemical readout offersadditional advantages in clinical diagnosticsapplications due to their relatively higher sensitivity and specificity, cost-effectiveness and compatibility with the miniaturization [23] [24] [25] .In these assays, sensor requires a surface-attached capture probe to hybridize the complementary target sequence, and form duplex DNA that intercalatively bind with a redox-active transition-metal cations (e.g., [Ru(NH3)6] 3+ ) for the generation of electrochemical signals [26] [27] [28] [29] . As described in many conventional electrochemical assays [30] [31] [32] [33] , the saturated amount of charge-compensation [Ru(NH3)6] 3+ complex (RuHex) on the electrode surface is electrochemically determined, which is directly proportional to the number of negatively charged phosphate residues and thereby the surface density of the target
DNA.
Previously, we demonstrated the use of direct adsorption of bisulfite treated and asymmetric PCR-amplified DNA sequences on to an unmodified gold electrode (without the use of complementary capture probe and hybridization step) to quantify the level of DNA methylation present in the sequence via measuring the total adsorbed DNA on to the electrode surface [34, 35] . Since the adsorption (i.e., physisorption) trend of the DNA bases to gold surfaces follows as adenine (A) > cytosine (C) > guanine (G)> thymine (T) [36, 37] 3-/4-system alone could be used for the interrogation of DNA methylation levelpresent in the bisulfite treated samples [34, 35] . While this assay is relatively simple, it follows an electron transfer kinetic-based mechanism, where density of the DNA sequences at the electrode surface should be sufficiently low [31] . Additionally, the risk of false-positive responses at low concentration of target is well known when using a detection technique based onattenuation of the interfacial electron transfer reaction of a redox process (i.e., "signal-off" approach).
In order to avoid this complexity, in the current study, weexplored whether simply monitoring the total charge generated by the electrostatically-attached RuHex onto the adsorbed DNA could report on the level of DNA methylation present in samples, where generated total redox charge is the function of adsorbed DNA sequences on the electrode surface [26] [27] [28] [29] . Since in this "signal-on" approach,the charge of the RuHex complex is quantitatively reflecting the amount of the adsorbed DNA at the electrode surface [30] , the electrochemical signal generated by the chronocoulometric (CC) interrogation of DNAbound RuHex will give the level of methylation present in the amplified samples.It is also important to note that unlike RuHexbased conventional methods [30] , the current method detects DNA methylation by simply monitoring the adsorbed target DNA on an unmodified SPE-Au electrode. Since we use direct adsorption of target DNA on an unmodified electrode rather than the conventional biosensing approach of using recognition and transduction layers, this method substantially simplifies the detection system by avoiding the complicated chemistries underlying each step of the sensor fabrication.
In this method,we first optimized the adsorption parameters (i. Blood and cell culture DNA mini kit (Qiagen, Hilden, Germany) was used for the purification of DNA from ESCC cell lines. All patients had not received pre-operative were free from radio/chemotherapy, matched with gender (all male) and clinical staging (stage III & IV).
Mean age group of the patients were 65±14 ranging from 45 to 74 years. Screen-printed gold electrodes were acquired from Dropsens (Spain).
Bisulfite modification
Bisulfite conversion and purification of the genomic DNA was performed with
MethylEasyXceed kit (Human Genetic Signatures Pty. Ltd., NSW, Australia) as recommended by the manufacturer. DNA quantification and purity was checked via Nanodrop Spectrophotometer (BioLab, Ipswich, MA, USA). Concentration of bisulfite treated DNA was noted in ng/µL and then stored at -20˚C until use. Approximately 500 ng genomic DNA from each samples were the starting amount for the bisulfite treatment.
DNA quantification
The DNA copy number normalization of 
Asymmetric PCR
Asymmetric PCR of the bisulfite treated DNA was carried out using AmpliTaq Gold 360 master mix (ThermFisher scientific, Waltham, MA USA) to generate ss-DNA amplicons. 
Determination of the surface area of the electrodes
Screen-printed electrode with the three-electrode system printed on a ceramic substrate (length 33 × width 10 × height 0.5 mm) were purchased from Dropsens (Spain). In the three- (taken to be 7.60 × 10 -5 cm 2 s -1 ), C is the concentration (mol cm -3 ), ν is the scan rate (Vs -1 ).
Electrochemical measurements of DNA methylation
All electrochemical measurements were performed on a CH1040C potentiostat (CH Instruments, TX, USA 
where Qtargetis the charge flowing through the target DNA-attached (methylated or unmethylated) electrode containing both Faradaic (redox) and non-Faradaic (capacitive) charges, and Qdl is the double-layer charge (capacitive charge) from the intercept at t = 0, respectively. The redox charge difference (Q) in CC signals between unmethylated and methylated was estimated using Eq. 3.
where , ℎ and , ℎ are the CC signalsestimated for the unmethylated and methylated samples, respectively.
Methylation specific-high resolution melting (MS-HRM) curve analysis
MS-HRM was carried out based on the modified versions of the previously published procedure [13] . Briefly, HRM curve analysis was demonstrated on the Rotor-Gene Q detection system (Qiagen) using the Rotor-Gene ScreenClust Software. PCR was performed in a 10 μL total volume containing 5 μL of 2Xsensimix HRM master mix, 1 μL of 20 ng/μL bisulfite modified genomic DNA, 2 μL RNase free water and 1 μL of each primer. The thermal profile comprised 15 min at 95°C, followed by 50 cycles of 30 seconds at 95°C, 30
seconds at 61°C and 20 second at 72°C. HRM analyses were carried out at temperature ramping from 70-95°C. The normalization of melting curve was performed as previously reported [40] .
Sanger sequencing
To further confirm the methylation status of FAM134B promoter region, we employed 
Statistical analysis
Statistical analyses were performed via pairwise comparisons between two conditions using student's t-test. Significance level of the tests was taken at p <0.05.
Results and discussion

Principle of the quantification of gene specific DNA methylation assay
We first extracted double stranded (ds)-DNA from the cancer cell lines and clinical tissue samples from ESCC patients to demonstrate the working principle of the method. We 
Synthetic sample design
Recent studies suggested thatalterations in FAM134B gene havea significantimpact in gastrointestinal carcinomas and neurological diseases via regulating its expression patterns and cellular autophagy [43] [44] [45] [46] . It has also been reported that FAM134B is mutated in metastatic lymph node tissues and its DNA copy number significant alteratedin oesophageal squamous cell carcinoma tissues [43] .In this proof-of-concept study, we have used gold-DNA affinity interaction for detecting gene-specific DNA methylation in FAM134Bpromoter region containing designated CpG sites located within a length of 48 bases. In order to execute our approach, we have designed synthetic samples containing 0, 1, 5 and 11 CpGsites within the promoter region of FAM134B gene which mimic the bisulfite treated and asymmetric PCR processed methylated and unmethylated DNA regions.
Assay Optimization
The extent of the adsorption of the target DNA on unmodified SPE-Au depends on the adsorption condition such as adsorption time, solution pH and amount of DNA. We first .55was achieved at neutral pH (i.e., 7), whereas at >pH = 7.0, a gradual decreases in charge density changes was recorded. These results clearly showed that pH of the buffer solution influence the competition between DNA and gold electrostatic forces (i.e., inherent interaction between DNA bases and gold electrodes). At neutral pH, negative charge of the phosphate backbone of DNA is optimal to hinder the adsorption of methylated samples while still allowing the unmethylated DNA with higher adenine contents to be adsorbed strongly.
At basic pH, the gold surface would be more negatively charged and electrostatic repulsion with the negatively-charged phosphate backbone of DNA could reduce overall DNA adsorption.On the other hand, at the lower pH (3), cytosines and adenine in the target sequences would be protonated which could facilitate faster adsorption for methylated and unmethylated samples resulting saturation ofboth targets on the gold surface within a very short time leading to a reduced level of charge density changes. Therefore, we selected pH 7
as an optimal pH for our assay.
Synthetic sample analysis
To evaluate the applicability of our approach for the detection ofvarious level of CpG methylation within the promoter region of FAM134Bgene, four synthetic DNA samples containing 0, 1, 5 and 11 CpG sites were examined. Fig. 3 shows that the decrease of the redox chargedensities is a function of the number of CpG cites. This is due to the decrease of the adenine contents with increasing methylated CpG sites in the target sequence (i.e., low clearlyindicates that our assay can effectively detect DNA methylation at a single CpG level of resolution. A similar result has also been reported previously based on gold-DNA [34] and graphene-DNA [40] affinity interaction based approaches.
Heterogonous sample analysis
Heterogeneous methylation can arise as a mixture of fully methylated and unmethylated DNA in varying proportions in tissue samples from cancer patients [47] .A heterogeneous mixture of cancer cells may contain both fully unmethylated and methylated DNA like imprinted gene H19 [48] .Accuratequantification of heterogeneous DNA methylation pattern plays critical role for the detection and prediction of clinical prognosis in human cancers [47] .
It is therefore important to screen the degree of methylation pattern in a high background of unmethylated DNA samples. To evaluate the assay performance for detecting heterogeneous DNA methylation pattern, we analysed the dependence of the CCresponses on various degree of methylation. The samples were made by mixing synthetic standards of methylated and unmethylated DNA sequences to get 0%, 10%, 25%, 50%, 75%, 90% and 100% methylation, Fig.4 . The total change densitiesdecrease with increasing levels of methylation, probably due to the increasing adenine contents in the target DNA sequences. The linear regression equation was found to be y (charge, µCcm -2 )= -0.8653 (% methylation)+102.6with a correlation coefficient (R 2 ) of 0.9998. A methylation change as low as 10% could be detected from 10ng/µL of DNA. This data clearly demonstrate that our approach is sensitive enough in detecting methylated DNA in the nanogram regime. It is important to note that this level of data was much better than the findings of our previous gold-DNA based approach [34, 35] , and was also comparable to recent approaches [18] [19] [20] [21] [22] .
Gene specific methylation detection and validation in cell line and clinical sample
To demonstrate a complex biological application, we applied our assay to detect the methylationstatus at the eleven CpG sites of the targeted FAM134B promoter which have been reported to be methylated in ESCC [40] . Purified DNA amplicons obtained from whole genome amplification and Jurkat DNA was used as fully unmethylated DNA and 100% methylated control, respectively. For avoiding any PCR bias, we quantified the gene copy number prior to PCR amplification [34, 35] .Purified genomic DNA samples generated from three ESSC cell lines were then amplified asymmetrically and analyzed using our approach under the optimized conditions, Fig in quantifying DNA methylation from these cell line samples analysis was found to be <5%.
These data were validated with MS-HRM curve analysis and Sanger sequencing. As can be seen in Fig S1, MS-HRM curve analysis showed that DNA samples derived from HKESC-4
is partially methylated while KYSE-510 and HKESC-1 DNA samples are hypermethylated.
Moreover, Sanger sequencing also confirmed the different degree methylation in WGA, Jurkat DNA and different ESCC cell lines sample ( Fig. S2 and 3 ). These data clearly indicate that the proposed assay could be a useful alternative for detecting FAM134B promoter gene methylation in cell-derived samples.
To further demonstrate the potential utility of our method in analysing clinical samples, we extended our assay to analyse eight tissue DNA samples derived from patients with primary ESCC. Two oesophageal non-cancerous tissue DNA samples were also used as a control (see Experimental for details). As indicated in Fig. 5D , all samples showed different degree of methylation. The level of total redox chargeof two normal samples clearly showed that these two samples are unmethylated in comparison to that of the WGA and Jurkat DNA samples. Similarly, by comparing the level of totalredox charges found for WGA and Jurkat DNA samples (Fig. 5C ), we can estimate that four DNA samples derived from P5, P6, P7 and P8 cancer patients were relatively highly methylated, while P1, P2, P3 and P4 samples were partially methylated (i.e., low methylation) at FAM134B promoter gene. We then validated our assay performance with well-known MS-HRM curve analysis and Sanger sequencing. As can be seen in Fig S1B and C, MS-HRM curve analysis identified almost similar methylation level in WGA, N1 and N2 samples. Also, P5, P6, P7 and P8 cancer patients were highly methylated with respect to that of P1, P2, P3 and P4 samples. Sanger sequencing also confirmed that P5, P6, P7 and P8 samples were relatively highly methylated (see typical sequencing data in Fig.S2-S4 ). Moreover, %RSD over three independent experiments in quantifying DNA methylation from clinical samples analysis were found to be <5%. These dataclearly indicated that CC signals generated by our assay were able to quantify different degree of DNA methylation in ESCC tissue samples. Also, our assay is highly reproducibile with greater sensitivity and specificity without costly fluorescence labels used in many of current methylation detection techniques [49] [50] [51] . In addition, validation studies with MS-HRM curve analysis and Sanger sequencing further suggested that our assay could detect DNA methylation in easy and inexpensive way from cancer patients.
Our method offers several advantages over current methodologies. First, the method involves the direct adsorption of target DNA onto an unmodified electrode rather than the conventional biosensing approach of using recognition and transduction layers, and hence it substantially simplifies the detection method by avoiding the use of complicated chemistries underlying each step of the sensor fabrication. It also avoids the use of capture probe as well as hybridization step. Second, it circumvents the need for the use of radioactive labels, methylation-sensitive restriction enzymes, antibodies, and sequencing analysis. Third, the use of commercially available and disposable SPE-Au (containing a three-electrode system) successfully eliminates the utilization of typical electrochemical cells, counter and reference electrodes thereby offering a relatively inexpensive (∼USD $5 per SPE-Au) platform for DNA methylation detection. Moreover, the use of SPE-Au potentially avoids the usual timeconsuming cleaning steps associated with conventional electrodes making the analysis much faster. Fourth, the detection step of our proposed assay can take only ten min in total (excluding bisulfite treatment and asymmetric PCR steps) to achieve electrochemical readout, which is considerably faster than many recent electrochemical DNA methylation assays [13, 29, 40] .
Conclusion
We have reported a simple and new method for the quantification of targeted 
